Vault-13

Ikarian Capital, LLC

DALLAS, TX · CIK 1778253 · 13F filing filed 2022-08-12

SEC-registered investment adviser since 2020 · limited liability company

As an employer

$241.2m reported value -26.6% vs Q1 2022
99positions
47.3%in top 10
18 new 13 added 40 reduced 74 sold out vs Q1 2022

Options: 29 call positions ($218.0m notional), 11 put positions ($89.2m notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 537,958 $14.5m6.01% 6.01% UnchangedShares held: Q3 2021 270.4k, Q4 2021 419.2k, Q1 2022 538.0k, Q2 2022 538.0k
2 ESPERION THERAPEUTICS INC NE COM ESPR ESPR 2,054,602 $13.1m5.42% 5.42% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 2.1m
3 HORIZON THERAPEUTICS PUB L SHS HZNP HZNP 160,116 $12.8m5.29% 5.29% AddedShares held: Q3 2021 25.7k, Q4 2021 75.7k, Q1 2022 110.1k, Q2 2022 160.1k +50.0k +50,000 45.4%
4 KARUNA THERAPEUTICS INC COM COM 100,000 $12.7m5.25% 5.25% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 100.0k +50.0k +50,000 100.0%
5 KEZAR LIFE SCIENCES INC COM COM 1,408,116 $11.6m4.83% 4.83% AddedShares held: Q3 2021 0, Q4 2021 1.0m, Q1 2022 1.1m, Q2 2022 1.4m +325.0k +325,000 30.0%
6 VERTEX PHARMACEUTICALS INC COM VRTX VRTX 40,000 $11.3m4.67% 4.67% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 25.0k, Q2 2022 40.0k +15.0k +15,000 60.0%
7 ALTIMMUNE INC COM NEW ALT ALT 897,359 $10.5m4.35% 4.35% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 897.4k
8 UNITED THERAPEUTICS CORP DEL COM UTHR UTHR 40,000 $9.4m3.91% 3.91% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 40.0k
9 BELLUS HEALTH INC NEW COM NEW BLU BLU 1,018,327 $9.4m3.90% 3.90% AddedShares held: Q3 2021 744.6k, Q4 2021 50.0k, Q1 2022 913.3k, Q2 2022 1.0m +105.0k +105,000 11.5%
10 ALNYLAM PHARMACEUTICALS INC COM ALNY ALNY 61,237 $8.9m3.70% 3.70% AddedShares held: Q3 2021 1.5k, Q4 2021 1.2k, Q1 2022 1.2k, Q2 2022 61.2k +60.0k +60,000 4850.4%
11 GOSSAMER BIO INC COM GOSS GOSS 1,000,387 $8.4m3.47% 3.47% AddedShares held: Q3 2021 1.4m, Q4 2021 1.2m, Q1 2022 775.3k, Q2 2022 1.0m +225.1k +225,072 29.0%
12 MILESTONE PHARMACEUTICALS IN COM MIST MIST 1,379,422 $8.2m3.40% 3.40% ReducedShares held: Q3 2021 1.8m, Q4 2021 1.8m, Q1 2022 1.9m, Q2 2022 1.4m -549.3k -549,330 -28.5%
13 XENON PHARMACEUTICALS INC COM XENE XENE 239,441 $7.3m3.02% 3.02% UnchangedShares held: Q3 2021 377.4k, Q4 2021 179.1k, Q1 2022 239.4k, Q2 2022 239.4k
14 TRACON PHARMACEUTICALS INC COM NEW COM NEW 2,788,853 $5.6m2.31% 2.31% ReducedShares held: Q3 2021 2.7m, Q4 2021 2.7m, Q1 2022 2.8m, Q2 2022 2.8m -54.4k -54,379 -1.9%
15 BIOMARIN PHARMACEUTICAL INC COM BMRN BMRN 60,000 $5.0m2.06% 2.06% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 50.0k, Q2 2022 60.0k +10.0k +10,000 20.0%
16 VAXCYTE INC COM PCVX PCVX 225,991 $4.9m2.04% 2.04% ReducedShares held: Q3 2021 295.1k, Q4 2021 295.1k, Q1 2022 316.0k, Q2 2022 226.0k -90.0k -90,000 -28.5%
17 GALAPAGOS NV SPON ADR LKFT LKFT 86,865 $4.8m2.00% 2.00% UnchangedShares held: Q3 2021 86.9k, Q4 2021 86.9k, Q1 2022 86.9k, Q2 2022 86.9k
18 AMYLYX PHARMACEUTICALS INC COM AMLX AMLX 246,554 $4.8m1.97% 1.97% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 396.7k, Q2 2022 246.6k -150.1k -150,100 -37.8%
19 SCPHARMACEUTICALS INC COM SCPH SCPH 884,008 $4.3m1.77% 1.77% ReducedShares held: Q3 2021 901.4k, Q4 2021 901.4k, Q1 2022 970.1k, Q2 2022 884.0k -86.1k -86,090 -8.9%
20 HARMONY BIOSCIENCES HLDGS IN COM HRMY HRMY 86,035 $4.2m1.74% 1.74% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 86.0k
21 PFIZER INC COM PFE PFE 80,000 $4.2m1.74% 1.74% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 80.0k, Q2 2022 80.0k
22 NEUROCRINE BIOSCIENCES INC COM NBIX NBIX 38,600 $3.8m1.56% 1.56% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 38.6k
23 KRANESHARES TR CSI CHI INTERNET KWEB KWEB 100,000 $3.3m1.36% 1.36% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 100.0k
24 SATSUMA PHARMACEUTICALS INC COM STSA STSA 653,448 $2.7m1.12% 1.12% UnchangedShares held: Q3 2021 629.4k, Q4 2021 629.4k, Q1 2022 653.4k, Q2 2022 653.4k
25 INSMED INC COM PAR $.01 INSM INSM 125,000 $2.5m1.02% 1.02% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 125.0k
26 VIKING THERAPEUTICS INC COM VKTX VKTX 835,275 $2.4m1.00% 1.00% AddedShares held: Q3 2021 500.6k, Q4 2021 500.6k, Q1 2022 532.4k, Q2 2022 835.3k +302.8k +302,846 56.9%
27 COGENT BIOSCIENCES INC COM COGT COGT 250,000 $2.3m0.94% 0.94% NewShares held: Q3 2021 30.7k, Q4 2021 0, Q1 2022 0, Q2 2022 250.0k
28 ADICET BIO INC COM COM 143,214 $2.1m0.87% 0.87% ReducedShares held: Q3 2021 392.4k, Q4 2021 477.4k, Q1 2022 507.3k, Q2 2022 143.2k -364.1k -364,134 -71.8%
29 LYRA THERAPEUTICS INC COM LYRA LYRA 347,338 $2.0m0.81% 0.81% ReducedShares held: Q3 2021 403.4k, Q4 2021 394.5k, Q1 2022 422.3k, Q2 2022 347.3k -75.0k -75,000 -17.8%
30 APELLIS PHARMACEUTICALS INC COM APLS APLS 41,900 $1.9m0.79% 0.79% NewShares held: Q3 2021 347.5k, Q4 2021 0, Q1 2022 0, Q2 2022 41.9k
31 SAREPTA THERAPEUTICS INC COM SRPT SRPT 25,000 $1.9m0.78% 0.78% NewShares held: Q3 2021 6.5k, Q4 2021 0, Q1 2022 0, Q2 2022 25.0k
32 SERES THERAPEUTICS INC COM COM 540,624 $1.9m0.77% 0.77% ReducedShares held: Q3 2021 606.6k, Q4 2021 795.9k, Q1 2022 840.6k, Q2 2022 540.6k -300.0k -300,000 -35.7%
33 ASTRIA THERAPEUTICS INC COM CATB CATB 592,123 $1.8m0.74% 0.74% AddedShares held: Q3 2021 87.6k, Q4 2021 87.6k, Q1 2022 92.2k, Q2 2022 592.1k +499.9k +499,900 542.1%
34 TERNS PHARMACEUTICALS INC COM COM 700,000 $1.7m0.72% 0.72% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 700.0k
35 X4 PHARMACEUTICALS INC COM COM 1,679,748 $1.6m0.67% 0.67% AddedShares held: Q3 2021 2.5m, Q4 2021 2.3m, Q1 2022 1.4m, Q2 2022 1.7m +307.7k +307,726 22.4%
36 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 375,000 $1.5m0.62% 0.62% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 375.0k, Q2 2022 375.0k
37 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 105,000 $1.4m0.60% 0.60% AddedShares held: Q3 2021 34.6k, Q4 2021 34.6k, Q1 2022 35.1k, Q2 2022 105.0k +69.9k +69,851 198.7%
38 DBV TECHNOLOGIES S A SPONSORED ADR SPONSORED ADR 316,939 $1.4m0.58% 0.58% UnchangedShares held: Q3 2021 310.1k, Q4 2021 310.1k, Q1 2022 316.9k, Q2 2022 316.9k
39 IMMATICS N.V SHS IMTX IMTX 157,190 $1.4m0.57% 0.57% ReducedShares held: Q3 2021 883.0k, Q4 2021 737.5k, Q1 2022 781.4k, Q2 2022 157.2k -624.2k -624,198 -79.9%
40 VASCULAR BIOGENICS LTD COM COM 830,007 $1.3m0.55% 0.55% ReducedShares held: Q3 2021 790.8k, Q4 2021 790.8k, Q1 2022 830.7k, Q2 2022 830.0k -740 -740 -0.1%
41 AADI BIOSCIENCE INC COM WHWK WHWK 412,343 $1.3m0.53% 0.53% AddedShares held: Q3 2021 11.4k, Q4 2021 196.4k, Q1 2022 208.4k, Q2 2022 412.3k +204.0k +203,975 97.9%
42 MERUS N V COM MRUS MRUS 53,703 $1.2m0.50% 0.50% UnchangedShares held: Q3 2021 50.9k, Q4 2021 50.9k, Q1 2022 53.7k, Q2 2022 53.7k
43 CABALETTA BIO INC COM CABA CABA 944,431 $1.0m0.41% 0.41% ReducedShares held: Q3 2021 1.2m, Q4 2021 970.4k, Q1 2022 1.0m, Q2 2022 944.4k -75.6k -75,639 -7.4%
44 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 268,104 $992.0k0.41% 0.41% UnchangedShares held: Q3 2021 285.3k, Q4 2021 265.3k, Q1 2022 268.1k, Q2 2022 268.1k
45 ARDELYX INC COM ARDX ARDX 1,680,552 $991.0k0.41% 0.41% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.7m
46 ANEBULO PHARMACEUTICALS INC COM ANEB ANEB 181,199 $942.0k0.39% 0.39% UnchangedShares held: Q3 2021 172.3k, Q4 2021 172.3k, Q1 2022 181.2k, Q2 2022 181.2k
47 FINCH THERAPEUTICS GROUP INC COM COM 330,523 $938.0k0.39% 0.39% UnchangedShares held: Q3 2021 315.7k, Q4 2021 315.7k, Q1 2022 330.5k, Q2 2022 330.5k
48 CHIMERIX INC COM CMRX CMRX 441,203 $917.0k0.38% 0.38% ReducedShares held: Q3 2021 801.3k, Q4 2021 795.4k, Q1 2022 841.2k, Q2 2022 441.2k -400.0k -400,000 -47.5%
49 AUTOLUS THERAPEUTICS PLC SPON ADS AUTL AUTL 322,217 $912.0k0.38% 0.38% ReducedShares held: Q3 2021 544.8k, Q4 2021 544.8k, Q1 2022 372.2k, Q2 2022 322.2k -50.0k -50,000 -13.4%
50 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 362,537 $884.0k0.37% 0.37% UnchangedShares held: Q3 2021 344.6k, Q4 2021 344.6k, Q1 2022 362.5k, Q2 2022 362.5k
51 RIGEL PHARMACEUTICALS INC COM NEW COM NEW 702,773 $794.0k0.33% 0.33% ReducedShares held: Q3 2021 0, Q4 2021 439.4k, Q1 2022 2.1m, Q2 2022 702.8k -1.4m -1,434,355 -67.1%
52 CLOVIS ONCOLOGY INC COM CLVS CLVS 422,339 $761.0k0.32% 0.32% ReducedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 772.3k, Q2 2022 422.3k -350.0k -350,000 -45.3%
53 AYALA PHARMACEUTICALS INC COM COM 697,316 $759.0k0.31% 0.31% ReducedShares held: Q3 2021 538.9k, Q4 2021 669.3k, Q1 2022 708.4k, Q2 2022 697.3k -11.1k -11,067 -1.6%
54 PROTARA THERAPEUTICS INC COM STK TARA TARA 257,853 $756.0k0.31% 0.31% ReducedShares held: Q3 2021 480.0k, Q4 2021 279.3k, Q1 2022 296.4k, Q2 2022 257.9k -38.6k -38,573 -13.0%
55 AILERON THERAPEUTICS INC COM ALRN ALRN 2,892,316 $752.0k0.31% 0.31% ReducedShares held: Q3 2021 2.8m, Q4 2021 2.8m, Q1 2022 2.9m, Q2 2022 2.9m -9.8k -9,770 -0.3%
56 GEMINI THERAPEUTICS INC COM COM 443,096 $749.0k0.31% 0.31% UnchangedShares held: Q3 2021 421.1k, Q4 2021 421.1k, Q1 2022 443.1k, Q2 2022 443.1k
57 BRAINSTORM CELL THERAPEUTICS COM NEW COM NEW 253,432 $698.0k0.29% 0.29% ReducedShares held: Q3 2021 289.6k, Q4 2021 289.6k, Q1 2022 304.2k, Q2 2022 253.4k -50.7k -50,729 -16.7%
58 PARDES BIOSCIENCES INC COM COM 223,934 $687.0k0.28% 0.28% ReducedShares held: Q3 2021 0, Q4 2021 400.0k, Q1 2022 323.9k, Q2 2022 223.9k -100.0k -100,000 -30.9%
59 REATA PHARMACEUTICALS INC CL A RETA RETA 20,805 $632.0k0.26% 0.26% ReducedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 86.9k, Q2 2022 20.8k -66.1k -66,100 -76.1%
60 BELLICUM PHARMACEUTICALS INC COM NEW BLCM BLCM 523,348 $617.0k0.26% 0.26% UnchangedShares held: Q3 2021 496.8k, Q4 2021 496.8k, Q1 2022 523.3k, Q2 2022 523.3k
61 SYNAPTOGENIX INC COM NEW COM NEW 121,191 $614.0k0.25% 0.25% ReducedShares held: Q3 2021 245.6k, Q4 2021 145.6k, Q1 2022 153.2k, Q2 2022 121.2k -32.0k -32,035 -20.9%
62 RENOVACOR INC COM COM 293,283 $595.0k0.25% 0.25% ReducedShares held: Q3 2021 442.9k, Q4 2021 342.9k, Q1 2022 343.3k, Q2 2022 293.3k -50.0k -50,000 -14.6%
63 CONNECT BIOPHARMA HLDGS LTD ADS ADS 677,859 $591.0k0.25% 0.25% UnchangedShares held: Q3 2021 0, Q4 2021 262.2k, Q1 2022 677.9k, Q2 2022 677.9k
64 INHIBRX INC COM INBX INBX 49,372 $561.0k0.23% 0.23% ReducedShares held: Q3 2021 289.9k, Q4 2021 149.8k, Q1 2022 157.8k, Q2 2022 49.4k -108.5k -108,470 -68.7%
65 SYNLOGIC INC COM COM 474,360 $545.0k0.23% 0.23% ReducedShares held: Q3 2021 788.8k, Q4 2021 483.8k, Q1 2022 519.8k, Q2 2022 474.4k -45.4k -45,415 -8.7%
66 EVOLUS INC COM EOLS EOLS 45,516 $529.0k0.22% 0.22% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 45.5k
67 RENEO PHARMACEUTICALS INC COM COM 185,597 $491.0k0.20% 0.20% UnchangedShares held: Q3 2021 175.0k, Q4 2021 175.0k, Q1 2022 185.6k, Q2 2022 185.6k
68 IVERIC BIO INC COM OPHT OPHT 49,099 $473.0k0.20% 0.20% UnchangedShares held: Q3 2021 216.5k, Q4 2021 46.5k, Q1 2022 49.1k, Q2 2022 49.1k
69 CASI PHARMACEUTICALS INC COM NEW CASI CASI 132,014 $378.0k0.16% 0.16% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 132.0k
70 NEXTCURE INC COM COM 71,435 $336.0k0.14% 0.14% ReducedShares held: Q3 2021 509.2k, Q4 2021 134.1k, Q1 2022 141.1k, Q2 2022 71.4k -69.6k -69,623 -49.4%
71 WAVE LIFE SCIENCES LTD SHS 96663EUR 96663EUR 98,039 $318.0k0.13% 0.13% ReducedShares held: Q3 2021 993.5k, Q4 2021 993.5k, Q1 2022 1.0m, Q2 2022 98.0k -950.0k -950,000 -90.7%
72 ZAI LAB LTD ADR ZLAB ZLAB 81,843 $278.0k0.12% 0.12% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 81.8k, Q2 2022 81.8k
73 VERASTEM INC COM COM 228,023 $265.0k0.11% 0.11% ReducedShares held: Q3 2021 1.2m, Q4 2021 637.4k, Q1 2022 678.0k, Q2 2022 228.0k -450.0k -450,000 -66.4%
74 IMMUNOPRECISE ANTIBODIES LTD COM NEW COM NEW 61,433 $237.0k0.10% 0.10% ReducedShares held: Q3 2021 73.9k, Q4 2021 73.9k, Q1 2022 77.7k, Q2 2022 61.4k -16.2k -16,217 -20.9%
75 HEPION PHARMACEUTICALS INC COM COM 410,189 $235.0k0.10% 0.10% ReducedShares held: Q3 2021 553.3k, Q4 2021 553.3k, Q1 2022 582.1k, Q2 2022 410.2k -171.9k -171,948 -29.5%
76 BIOGEN INC COM BIIB BIIB 1,122 $228.0k0.09% 0.09% UnchangedShares held: Q3 2021 32.2k, Q4 2021 29.5k, Q1 2022 1.1k, Q2 2022 1.1k
77 CORBUS PHARMACEUTICALS HLDGS COM CRBP CRBP 862,527 $217.0k0.09% 0.09% ReducedShares held: Q3 2021 948.5k, Q4 2021 948.5k, Q1 2022 997.6k, Q2 2022 862.5k -135.1k -135,100 -13.5%
78 REGULUS THERAPEUTICS INC COM RGLS RGLS 105,341 $217.0k0.09% 0.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 105.3k
79 IMMUNIC INC COM COM 61,500 $214.0k0.09% 0.09% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 61.5k
80 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 300,000 $200.0k0.08% 0.08% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 300.0k
81 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 615,856 $199.0k0.08% 0.08% ReducedShares held: Q3 2021 903.7k, Q4 2021 853.7k, Q1 2022 915.9k, Q2 2022 615.9k -300.0k -300,000 -32.8%
82 YUMANITY THERAPEUTICS INC COM COM 104,392 $190.0k0.08% 0.08% ReducedShares held: Q3 2021 228.8k, Q4 2021 228.8k, Q1 2022 236.3k, Q2 2022 104.4k -131.9k -131,892 -55.8%
83 ASLAN PHARMACEUTICALS LTD ADS ADS 970,747 $185.0k0.08% 0.08% UnchangedShares held: Q3 2021 1.4m, Q4 2021 917.3k, Q1 2022 970.7k, Q2 2022 970.7k
84 CLENE INC COMMON STOCK CLNN CLNN 70,000 $177.0k0.07% 0.07% ReducedShares held: Q3 2021 489.3k, Q4 2021 489.3k, Q1 2022 514.3k, Q2 2022 70.0k -444.3k -444,283 -86.4%
85 MYMD PHARMACEUTICALS INC COM COM 81,089 $176.0k0.07% 0.07% ReducedShares held: Q3 2021 0, Q4 2021 124.0k, Q1 2022 131.4k, Q2 2022 81.1k -50.3k -50,300 -38.3%
86 MUSTANG BIO INC COM MBIO MBIO 246,824 $145.0k0.06% 0.06% ReducedShares held: Q3 2021 506.0k, Q4 2021 506.0k, Q1 2022 546.8k, Q2 2022 246.8k -300.0k -300,000 -54.9%
87 TEMPEST THERAPEUTICS INC COM COM 61,827 $132.0k0.05% 0.05% UnchangedShares held: Q3 2021 58.8k, Q4 2021 58.8k, Q1 2022 61.8k, Q2 2022 61.8k
88 STEALTH BIOTHERAPEUTICS CORP SPONSORED ADS SPONSORED ADS 501,836 $127.0k0.05% 0.05% UnchangedShares held: Q3 2021 478.6k, Q4 2021 478.6k, Q1 2022 501.8k, Q2 2022 501.8k
89 CYCLACEL PHARMACEUTICALS INC COM COM 104,741 $113.0k0.05% 0.05% UnchangedShares held: Q3 2021 99.4k, Q4 2021 99.4k, Q1 2022 104.7k, Q2 2022 104.7k
90 LARIMAR THERAPEUTICS INC COM LRMR LRMR 51,606 $100.0k0.04% 0.04% UnchangedShares held: Q3 2021 47.2k, Q4 2021 47.2k, Q1 2022 51.6k, Q2 2022 51.6k
91 INVENTIVA SA ADS IVA IVA 15,579 $93.0k0.04% 0.04% UnchangedShares held: Q3 2021 14.7k, Q4 2021 14.7k, Q1 2022 15.6k, Q2 2022 15.6k
92 BRIGHT MINDS BIOSCIENCES INC COM COM 105,958 $86.0k0.04% 0.04% UnchangedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 106.0k, Q2 2022 106.0k
93 MIND MEDICINE MINDMED INC COM SUB VTG COM SUB VTG 105,958 $68.0k0.03% 0.03% UnchangedShares held: Q3 2021 0, Q4 2021 100.0k, Q1 2022 106.0k, Q2 2022 106.0k
94 OVID THERAPEUTICS INC COM OVID OVID 26,831 $59.0k0.02% 0.02% ReducedShares held: Q3 2021 1.1m, Q4 2021 705.1k, Q1 2022 738.4k, Q2 2022 26.8k -711.5k -711,541 -96.4%
95 ENVERIC BIOSCIENCES INC COM NEW COM NEW 223,834 $48.0k0.02% 0.02% ReducedShares held: Q3 2021 0, Q4 2021 400.0k, Q1 2022 423.8k, Q2 2022 223.8k -200.0k -200,000 -47.2%
96 ALTAMIRA THERAPEUTICS LTD SHS CYTOF CYTOF 75,000 $36.0k0.01% 0.01% ReducedShares held: Q3 2021 399.1k, Q4 2021 304.8k, Q1 2022 320.0k, Q2 2022 75.0k -245.0k -245,010 -76.6%
97 BAUDAX BIO INC COM NEW COM NEW 2,966 $3.0k0.00% 0.00% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 3.0k, Q2 2022 3.0k
98 CHINOOK THERAPEUTICS INC COM ADRO ADRO 332,295 $00.00% 0.00% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 332.3k
99 OTONOMY INC COM OTIC OTIC 180 $00.00% 0.00% ReducedShares held: Q3 2021 208.3k, Q4 2021 208.3k, Q1 2022 218.5k, Q2 2022 180 -218.4k -218,358 -99.9%

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
BICYCLE THERAPEUTICS PLC BCYC BCYC 478,784 $21.0m478.8k shares
ZENTALIS PHARMACEUTICALS INC ZNTL ZNTL 202,203 $9.3m202.2k shares
SAGE THERAPEUTICS INC SAGE SAGE 249,907 $8.3m249.9k shares
BIOHAVEN PHARMACTL HLDG CO L BHVN BHVN 60,000 $7.1m60.0k shares
SIERRA ONCOLOGY INC 217,915 $7.0m217.9k shares
AMGEN INC AMGN AMGN 20,000 $4.8m20.0k shares
INTELLIA THERAPEUTICS INC NTLA NTLA 47,408 $3.4m47.4k shares
SAVARA INC SVRA SVRA 1,622,552 $2.1m1.6m shares
KYMERA THERAPEUTICS INC KYMR KYMR 50,000 $2.1m50.0k shares
LIQUIDIA CORPORATION LQDA LQDA 243,904 $1.8m243.9k shares
GLOBAL BLOOD THERAPEUTICS IN GBT GBT 49,997 $1.7m50.0k shares
MACROGENICS INC MGNX MGNX 164,119 $1.4m164.1k shares
NUVATION BIO INC NUVB NUVB 213,310 $1.1m213.3k shares
AURINIA PHARMACEUTICALS INC AUPH AUPH 87,071 $1.1m87.1k shares
PHATHOM PHARMACEUTICALS INC PHAT PHAT 78,550 $1.1m78.5k shares
CASI PHARMACEUTICALS INC CASI CASI 1,320,155 $1.1m1.3m shares
ASCENDIS PHARMA A/S 8,763 $1.0m8.8k shares
MAXCYTE INC MXCT MXCT 137,958 $964.0k138.0k shares
CORVUS PHARMACEUTICALS INC CRVS CRVS 510,126 $837.0k510.1k shares
BCLS ACQUISITION CORP 77,274 $762.0k77.3k shares
PANBELA THERAPEUTICS INC 355,959 $750.0k356.0k shares
QUANTUM SI INC QSI QSI 157,363 $736.0k157.4k shares
INFLARX NV IFRX IFRX 349,468 $639.0k349.5k shares
PLIANT THERAPEUTICS INC PLRX PLRX 90,805 $636.0k90.8k shares
VISTAGEN THERAPEUTICS INC VTGN VTGN 511,186 $633.0k511.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
ALNYLAM PHARMACEUTICALS INC ALNY · Call ALNYCall 291,300 $42.5m291.3k shares Added
SPDR SER TR XBI · Put XBIPut 350,000 $26.0m350.0k shares New
AMGEN INC AMGN · Call AMGNCall 100,000 $24.3m100.0k shares Unchanged
BIOGEN INC BIIB · Call BIIBCall 112,200 $22.9m112.2k shares Unchanged
AXSOME THERAPEUTICS INC AXSM · Put AXSMPut 500,000 $19.2m500.0k shares New
CELLDEX THERAPEUTICS INC NEW CLDX · Put CLDXPut 616,700 $16.6m616.7k shares Added
CELLDEX THERAPEUTICS INC NEW CLDX · Call CLDXCall 506,500 $13.7m506.5k shares Added
AXSOME THERAPEUTICS INC AXSM · Call AXSMCall 350,000 $13.4m350.0k shares New
KARUNA THERAPEUTICS INC Put Put 100,000 $12.7m100.0k shares New
KEZAR LIFE SCIENCES INC Call Call 1,075,300 $8.9m1.1m shares Added
BIOMARIN PHARMACEUTICAL INC BMRN · Call BMRNCall 106,700 $8.8m106.7k shares Reduced
SAGE THERAPEUTICS INC SAGE · Call SAGECall 250,000 $8.1m250.0k shares Unchanged
HORIZON THERAPEUTICS PUB L HZNP · Call HZNPCall 100,000 $8.0m100.0k shares Reduced
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 100,000 $7.5m100.0k shares New
AMYLYX PHARMACEUTICALS INC AMLX · Call AMLXCall 350,800 $6.8m350.8k shares Added
LANTHEUS HLDGS INC LNTH · Call LNTHCall 100,000 $6.6m100.0k shares New
ALNYLAM PHARMACEUTICALS INC ALNY · Put ALNYPut 39,900 $5.8m39.9k shares Reduced
RELMADA THERAPEUTICS INC RLMD · Call RLMDCall 300,000 $5.7m300.0k shares New
APELLIS PHARMACEUTICALS INC APLS · Call APLSCall 123,200 $5.6m123.2k shares Reduced
RELMADA THERAPEUTICS INC RLMD · Put RLMDPut 282,300 $5.4m282.3k shares New
REATA PHARMACEUTICALS INC RETA · Call RETACall 162,000 $4.9m162.0k shares Added
INTERCEPT PHARMACEUTICALS IN ICPT · Call ICPTCall 350,000 $4.8m350.0k shares New
ALTIMMUNE INC ALT · Call ALTCall 303,600 $3.6m303.6k shares New
VIRIDIAN THERAPEUTICS INC VRDN · Call VRDNCall 300,000 $3.5m300.0k shares New
BLUEPRINT MEDICINES CORP BPMC · Call BPMCCall 64,000 $3.2m64.0k shares Unchanged

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
NEXTCURE INC NXTC · 13G · filed 2026-08-14 NXTC 10.0%≈ $804.3k no change 13G 2026-08-14
CNS PHARMACEUTICALS INC CNSP · 13G · filed 2026-08-14 CNSP 9.9%≈ $704.0k +4.2 pts 13G 2026-08-14
TRAWS PHARMA INC TRAW · 13G · filed 2026-08-14 TRAW 9.5%≈ $1.3m -0.5 pts 13G 2026-08-14
QUINCE THERAPEUTICS INC IRLA · 13G · filed 2026-08-14 IRLA 9.0%≈ $1.7m new 13G 2026-08-14
PELTHOS THERAPEUTICS INC PTHS · 13G · filed 2026-05-15 PTHS 7.7%≈ $7.3m -0.7 pts 13G 2026-05-15
CHANNEL THERAPEUTICS CORPORA 13G · filed 2025-02-14 7.3% new 13G 2025-02-14
CONNECT BIOPHARMA HLDGS LTD 13G · filed 2026-08-14 6.9% -1.9 pts 13G 2026-08-14
LIPOCINE INC NEW LPCN · 13G · filed 2026-05-15 LPCN 6.3% new 13G 2026-05-15